Now showing items 1-3 of 3

    • Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population 

      Reiner, Anne S; Lynch, Charles F; Sisti, Julia S; John, Esther M; Brooks, Jennifer D; Bernstein, Leslie; Knight, Julia A et al. (2017-07-19)
      Abstract Background Previous population-based studies have described first primary breast cancer tumor characteristics and their association with contralateral breast cancer ...
    • Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population 

      Reiner, Anne S; Lynch, Charles F; Sisti, Julia S; John, Esther M; Brooks, Jennifer D; Bernstein, Leslie; Knight, Julia A et al. (2017-07-19)
      Abstract Background Previous population-based studies have described first primary breast cancer tumor characteristics and their association with contralateral breast cancer ...
    • No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing 

      Easton, Douglas F; Lesueur, Fabienne; Decker, Brennan; Michailidou, Kyriaki; Li, Jun; Allen, Jamie; Luccarini, Craig et al. (BMJ Group, 2016-02-26)
      Background BRCA1 interacting protein C-terminal helicase 1 (BRIP1) is one of the Fanconi Anaemia Complementation (FANC) group family of DNA repair proteins. Biallelic mutations in BRIP1 are responsible for FANC group J, and ...